نتایج جستجو برای: تومور مارکر ca125

تعداد نتایج: 5813  

ژورنال: :مجله دانشگاه علوم پزشکی مازندران 0
صنمبر صدیقی عیسی جهانزاد لاله قدیریان جهانگیر رافت ساقی وزیری صبا واحدی

سابقه و هدف: بروز تومورهای نورواندوکرین در سال های اخیر رو به افزایش بوده است. تومورهای نورواندوکرین تنوع زیادی از نقطه نظر تظاهرات بالینی، مرحله و درجه بدخیمی دارند. همچنین استفاده از مارکرهایی چون ki67 می توانند به تعیین مرحله بیماری کمک نمایند. بررسی شیوع بیمارستانی تومورهای نورواندوکرین، منشأ اولیه تومور، بررسی ارتباط تشخیص پاتولوژی و ایمونوهیستوشیمی با سطح ki67، هدف انجام این تحقیق بود. مو...

ژورنال: :مجله دانشگاه علوم پزشکی اردبیل 0
داور امانی davar amani محمد حسن زهیر mohammadhasan zahir مجتبی کریم زاده mojtaba karimzadeh صادق فیض اله زاده sadegh feizollah zadeh محمد حسین دهقان mohammadhosein dehghan

زمینه و هدف: لنفوسیتهای ارتشاح یافته به تومور (tils (tumor infiltrating lymphocytes عامل شناسایی ودفاع بر علیه سلولهای توموری بدخیم توسط سیستم ایمنی میزبان بوده وسلولهای t، بیشترین سلولهای ایمنی ارتشاح یافته به داخل تومور هستند. اطلاعات متناقضی درباره سلولهایt داخل تومور وجود دارد و مکانیسم های متعددی برای توضیح ناکارایی tils پیشنهاد شده است. هدف این مطالعه بررسی وضعیت ایمنی لنفوسیتهایt ارتشاح ...

Journal: :European heart journal 2010
Julio Núñez Juan Sanchis Vicent Bodí Gregg C Fonarow Eduardo Núñez Vicente Bertomeu-González Gema Miñana Luciano Consuegra Maria José Bosch Arturo Carratalá Francisco J Chorro Angel Llàcer

AIM Elevated brain natriuretic peptide (BNP) and tumour marker antigen carbohydrate 125 (CA125) levels have shown to be associated with higher risk for adverse outcomes in patients with acute heart failure (AHF). Nevertheless, no attempt has been made to explore the utility of combining these two biomarkers. We sought to assess whether CA125 adds prognostic value to BNP in predicting 6-month al...

Journal: :Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2012
Nicole Urban Jason Thorpe Beth Y Karlan Martin W McIntosh Melanie R Palomares Mary B Daly Pamela Paley Charles W Drescher

BACKGROUND Human epididymis protein 4 (HE4) is approved for clinical use with CA125 to predict epithelial ovarian cancer in women with a pelvic mass or in remission after chemotherapy. Previously reported reference ranges for HE4 are inconsistent. METHODS We report positivity thresholds yielding 90%, 95%, 98%, and 99% specificity for age-defined populations of healthy women for HE4, CA125, an...

2017
Nienke Zwakman Rafli van de Laar Toon Van Gorp Petra L M Zusterzeel Marc P M L Snijders Isabel Ferreira Leon F A G Massuger Roy F P M Kruitwagen

OBJECTIVE In patients with advanced stage epithelial ovarian cancer (EOC) the volume of residual tumor after debulking is known as prognostic factor for survival. We wanted to examine the relationship between postoperative decline in serum CA125 and residual disease after cytoreductive surgery and evaluate perioperative changes in serum CA125 levels as predictor for disease-specific survival. ...

Journal: :Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2011
Deirisa Lopes Barreto Annemieke M Coester Marlies Noordzij Watske Smit Dirk G Struijk Susan Rogers Dirk R de Waart Raymond T Krediet

BACKGROUND Cancer antigen (CA) 125 is a glycoprotein that provides data on the state of the peritoneal membrane in peritoneal dialysis (PD). Interleukin-6 (IL-6) acts as a mediator in acute-phase responses. The study evaluated the usefulness of CA125 and IL-6 in random effluent samples, by assessing their variability in individual patients during clinical practice at the outpatient department. ...

ژورنال: طب جنوب 2020
Bolkheir , AmirReza, Cheraghi , Fatemeh, Zargar , Mahvash,

  Background: Given that ovarian cancer symptoms are nonspecific and that appropriate surgical staging and pathological grading are important for the best treatment and prognosis of patients, this study aimed to determine the correlation of preoperative serum levels of CA125 and He4 with staging and grading. Materials and Methods: This cross-sectional study recruited 29 patients with epithelial...

2016
Wei Wang Xiao-Long Chen Shen-Yu Zhao Yu-Hui Xu Wei-Han Zhang Kai Liu Xin-Zu Chen Kun Yang Bo Zhang Zhi-Xin Chen Jia-Ping Chen Zong-Guang Zhou Jian-Kun Hu

The prognostic significance of preoperative serum CA125, CA19-9 and CEA in gastric carcinoma (GC) has been widely reported and is still under debate. Here, we evaluated the prognostic significance of preoperative serum CA125, CA19-9 and CEA in patients with GC. 1692 patients with GC who underwent gastrectomy were divided into the training (from January 2005 to December 2011, n = 1024) and the v...

2016
Nabil Abdalla Robert Piorkowski Anna Slomka Malgorzata Kania Wlodzimierz Sawicki Krzysztof Cendrowski

THE AIM OF THE STUDY To assess the difference of serum level of HE4 and CA125 among patients with endometrioid endometrial cancer, considering the presence or absence of selected risk factors. MATERIAL AND METHODS A retrospective study of 46 patients, whose serum level of HE4 and CA125 level was documented, admitted to our Clinic because of endometrioid endometrial cancer. The statistical dif...

Journal: :Japanese journal of infectious diseases 2008
Sefa Levent Ozsahin Bulent Turgut Naim Nur Omer Tamer Dogan Taner Erselcan Serdar Berk

The aim of the current study was to determine the possible crucial role of cancer antigen 125 (CA125) in the diagnosis of pulmonary tuberculosis (PTB). The CA125 levels of study and control groups were statistically compared. In a total of 146 patients that were included in the current study, 30 had active PTB, 37 inactive PTB, 28 community-acquired pneumonia (CAP), 25 pleural or pulmonary mali...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید